Metabolomic signatures for diagnosis and clinical severity in Parkinson's disease
Summary Background Parkinson's disease (PD) remains challenging to diagnose at early stages owing to subtle and heterogeneous clinical manifestations and the lack of reliable biomarkers. Metabolomics offers a powerful approach to capture disease-related biochemical alterations that reflect underlying pathophysiology. T...